ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Daidzein alleviates doxorubicin-induced heart failure via the SIRT3/FOXO3a signaling pathway

Li, Huaxin; Zhang, Mengxue; Wang, Yuanyu; Gong, Ke; Yan, Tengteng; Wang, Dandan; Meng, Xianshe; Yang, Xiaoxiao; Chen, Yuanli; Han, Jihong; Duan, Yajun*; Zhang, Shuang*南开大学; 1
Food & Function2022-9-22DOI: 10.1039/d2fo00772j
8被引7阅读
引用收藏
分享

摘要

Heart failure (HF) is a clinical syndrome characterized by typical symptoms that usually occur at the end stage of various heart diseases and lead to death. Daidzein (DAI), an isoflavone found in soy foods, is widely used to treat menopausal syndrome, prostate cancer, breast cancer, heart disease, cardiovascular disease, and osteoporosis, and has anti-oxidant and anti-inflammatory properties. However, the effects of DAI in HF remain unknown. In this study, doxorubicin (DOX) was used to establish HF models of C57BL/6J mice and H9c2 cells with DAI treatment. Our results showed that DAI markedly improved the DOX-induced decline in cardiac function, and decreased the left ventricular ejection fraction, cardiac inflammation, oxidative stress, apoptosis, and fibrosis. Mechanistically, DAI affects cardiac energy metabolism by regulating SIRT3, and meets the ATP demand of the heart by improving glucose, lipid, and ketone body metabolism as well as restoring mitochondrial dysfunction in vivo and in vitro. Additionally, DAI can exert an antioxidant function and alleviate HF through the SIRT3/FOXO3a pathway. In conclusion, we demonstrate that DAI alleviates DOX-induced cardiotoxicity by regulating cardiac energy metabolism as well as reducing inflammation, oxidative stress, apoptosis and fibrosis, indicating its potential application for HF treatment.

学科与关键词

关键词
OXIDATIVE STRESSBCL-2 FAMILYAPOPTOSISINFLAMMATION
相关
加载中…
  • Afzelin protects against doxorubicin-induced cardiotoxicity by promoting the AMPKα/SIRT1 signaling pathway
    Sun, Yixin; Guo, Danyang; Yue, Saiding; Zhou, Mingyan; Wang, Dongxu; Chen, Fengjiao; Wang, Lingling*Toxicology and Applied Pharmacology, 2023, 477: 116687.被引 1
  • Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3
    Zhang, Wei; Fan, Zhixing; Wang, Fengyuan; Yin, Lin; Wu, Jinchun; Li, Dengke; Song, Siwei; Wang, Xi; Tang, Yanhong; Huang, Congxin*Oxidative Medicine and Cellular Longevity, 2023, 2023: 9966355.被引 6
  • Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway
    Li, Xiaoqi; Wang, Xin; Wang, Binyu; Chi, Weiqun; Li, Zhangyi; Zhang, Min; Shen, Yifu; Liu, Xu; Lu, Youmei; Liu, Yu*PHYTOMEDICINE, 2022, 99: 154027.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Food & Function
发表日期
2022-09-22
卷期
第 13 卷, 第 18 期
页码
9576-9588
DOI
10.1039/d2fo00772j
语言
ENGLISH
成果收录
SCIE
资助标注
China NSFC [82173807, 81773727, 81973316]; Tianjin Municipal Science and Technology Commission of China [20JCZDJC00710]; Fundamental Research Funds for the Central Universities (Nankai University) [63211045]; Fundamental Research Funds for the Central Universities (Hefei University of Technology) [JZ2021HGTA0127]

作者

  • L

    Li, Huaxin (第一作者)

  • Z

    Zhang, Mengxue

查看全部 12 位作者收起作者
  • W

    Wang, Yuanyu

    beijing inst biomed

  • G

    Gong, Ke

  • Y

    Yan, Tengteng

  • W

    Wang, Dandan

    anhui univ

  • M

    Meng, Xianshe

  • Y

    Yang, Xiaoxiao

  • C

    Chen, Yuanli

  • H

    Han, Jihong

    nankai univ

  • D

    Duan, Yajun (通讯)

    1 · univ sci & technol china · ustc

  • Z

    Zhang, Shuang (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417